Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $150 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Jennie Daisak

Jennie Daisak

Associate
Life Sciences
Boston

Experience

Ms. Daisak joined Bain Capital Life Sciences in 2021. She is an Associate. 

Prior to joining Bain Capital, Ms. Daisak worked at J.P. Morgan in their healthcare investment banking group, advising biotechnology and pharmaceutical clients on a range of strategic alternatives including M&A and debt/equity financings.  
 


Education

Ms. Daisak graduated summa cum laude from the Roy and Diana Vagelos Program in Life Sciences & Management at the University of Pennsylvania, where she earned both a B.A. in Biology and B.S. in Economics from the Wharton School with a concentration in Finance.